VULNERABILITY NETWORK
Live / Applied — Fourth extension granted (statement of use) (as of 18 Nov 2025)
What this means for you
Not registered yet, but its 23 Jun 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97472735
- Mark type
- Stylized text
- Filed
- 23 Jun 2022
- Published for opposition
- 17 Oct 2023
- Attorney of record
- Karen Won
Goods and services
- Class 042 — Scientific and technological services: Scientific research consulting services in the field of medicine, genetics, oncology, biology, biotechnology and pharmaceuticals; scientific research services, namely, analysis of scientific and clinical data in the fields of genetic, biologic, and oncologic data; scientific research consulting in the fields of healthcare, medicine, genetics, oncology, biology, and pharmaceuticals; genetic mapping for scientific and medical purposes; providing medical and scientific research information in the fields of genetics, oncology, biology, and pharmaceuticals; drug discovery services; providing scientific, medical, and clinical research and scientific consulting services in the fields of genetics, oncology, biology, and pharmaceuticals by using machine learning technology, artificial intelligence technology, and biotechnology methods; medical and scientific research and scientific consulting, namely, designing and supporting clinical trials for others; scientific research and development services in the collection of information and data on biologicals for research purposes; providing on-line searchable genetic reference databases being collections of gene sequences for scientific research purposes; scientific research services, namely, disease modeling for research purposes; scientific analysis services using machine-learning algorithms for analysis of bioinformatics data in the field of research and development of therapeutic biomolecules for the treatment of cancer and other diseases; scientific research in the field of biomarker rankings; scientific research and development of pharmaceutical preparations and medicines; pharmaceutical drug development services; consulting services in the field of pharmaceutical research and development; medical and scientific research in the field of cancer treatment and diagnosis
- Class 044 — Medical, beauty and agricultural services: Consulting services in the field of healthcare; medical analysis services of healthcare, medical, genetic, scientific, biologic, clinical and oncologic data relating to the treatment of persons; healthcare and medical services, namely, providing databases in the fields of genetic, oncological, and biological information for inputting, collecting, analyzing and managing scientific data for treatment and diagnostic purposes; healthcare services, namely, medical services in the nature of analyzing scientific genetic, oncological, and biological data for treatment and diagnostic purposes by using machine learning and artificial intelligence technologies; providing clinical medical consulting services in the fields of genetics, oncology, biology, and pharmaceuticals by using machine learning technology, artificial intelligence technology, and biotechnology methods
Owner
- Zephyr AI, Inc., Dallas, TX, US
- Zephyr AI, Inc., Dallas, TX, US
Prosecution history
- 19 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Nov 2025 — SOU EXTENSION 4 GRANTED
- 18 Nov 2025 — SOU EXTENSION 4 FILED
- 18 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 08 Oct 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 08 Oct 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 08 Oct 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 08 Oct 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 08 Oct 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 May 2025 — SOU EXTENSION 3 GRANTED
- 27 May 2025 — SOU EXTENSION 3 FILED
- 27 May 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Dec 2024 — SOU EXTENSION 2 GRANTED